Xeris Biopharma Holdings, Inc. ( XERS) - Key Metrics
XERS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.53 | -$0.18 | $0.05 | $0.05 |
| 2026Q1 | $0.49 | $0.01 | $0.06 | $0.06 |
| 2025Q4 | $0.52 | $0.07 | $0.12 | $0.12 |
| 2025Q3 | $0.42 | $0 | $0.10 | $0.10 |
| 2025Q2 | $0.46 | -$0.01 | $0 | $0 |
XERS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11 |
| 2026Q1 | 0% | 110.69 |
| 2025Q4 | 0% | 29.38 |
| 2025Q3 | 0% | 678.33 |
| 2025Q2 | 0% | -96.49 |
XERS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.59% | 0% |
| 2026Q1 | 0.97% | 0% |
| 2025Q4 | 1.51% | 0% |
| 2025Q3 | 1.25% | 0% |
| 2025Q2 | -0.01% | 0% |
XERS
Price: $8.60
52 week price:
Earnings Per Share: -0.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 485000
Market Capitalization: 1.5 billion